Related Experiment Video
Updated: Aug 20, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Glucocorticoid receptor and RAS: an unexpected couple in cancer
Ion C Cirstea1, Herwig P Moll2, Jan Tuckermann1
1Institute of Comparative Molecular Endocrinology, University of Ulm, Helmholtzstrasse 8/1, 89081 Ulm, Germany.
Abstract:
Constitutively activated rat sarcoma (RAS) GTPases are one of the major drivers of tumor growth and are difficult drug targets. The glucocorticoid receptor (GR), a nuclear receptor primarily acting in the nucleus, is a potent modulator of inflammation and regulator of metabolism and cell growth. Emerging evidence has revealed that GR modulates RAS-dependent signaling and RAS activation. The unliganded GR decreases RAS activation, and, upon ligand binding, GR leaves RAS complexes, is translocated into the nucleus, and unleashes the activation of RAS and its downstream pathways. GR forms a complex with RAS and RAF1 and their associated proteins, such as members of the 14-3-3 family of adapter proteins. The exploration of RAS-GR complex formation and maintenance will help to develop much-needed breakthroughs in oncogenic RAS biology and thus help to alleviate tumor growth and burden.
Insights
Activated rat sarcoma (RAS) GTPases drive tumor growth. Glucocorticoid receptor (GR) modulates RAS activation; unliganded GR inhibits it, while ligand-bound GR unleashes RAS signaling, impacting cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Constitutively activated rat sarcoma (RAS) GTPases are key drivers of tumor growth and challenging therapeutic targets.
- The glucocorticoid receptor (GR) is a nuclear receptor involved in inflammation, metabolism, and cell growth regulation.
Purpose of the Study:
- To investigate the role of the glucocorticoid receptor (GR) in modulating RAS-dependent signaling and RAS activation.
- To explore the formation and maintenance of RAS-GR complexes for potential oncogenic RAS biology breakthroughs.
Main Methods:
- Investigated the interaction between GR and RAS-RAF1 complexes.
- Analyzed the effect of ligand binding on GR localization and RAS activation.
Main Results:
- Unliganded GR decreases RAS activation.
- Ligand binding causes GR to leave RAS complexes, translocate to the nucleus, and activate RAS pathways.
- GR forms complexes with RAS, RAF1, and 14-3-3 proteins.
Conclusions:
- GR plays a critical role in regulating RAS activation, offering a potential therapeutic avenue.
- Understanding RAS-GR complex dynamics is crucial for developing novel treatments for RAS-driven cancers.
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

